CLINICAL_TRIALS
trial_result
· 2021-07-16
Clinical Trial Update: Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema [Phase 2, Phase 3]
Summary
Phase 2/3 clinical trial evaluating physiologic parameters to study mechanism of action of the Lung Volume Reduction Coil in subjects with homogeneous emphysema…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Emphysema | Phase 2, Phase 3 | Status: COMPLETED